CONTACT US
CLINICAL TRIAL NEWS: MM-398 combined with standard chemotherapy boosts overall survival by nearly 2 months in patients previously treated with gemcitabine. Learn more.
New Chemotherapy Combination Extends Survival
Facing Pancreatic Cancer?
We're here to help
No one should face pancreatic cancer alone. Learn how we can support you.
(877) 272-6226
Mon – Fri, 7 a.m. – 5 p.m. PST
You can also contact us using the below form.
